SMAD2 and non-small cell lung carcinoma: As a SMAD2-specific interaction protein, CCT6A acts as an inhibitor of SMAD2 in NSCLC, thereby promoting TGF-β1-mediated NSCLC transfer (Ying et al., 2017).